As governments enacted physical distancing measures worldwide in response to the COVID-19 pandemic, organizations in every industry quickly had to adapt to new ways of working—including remote work.
CGI's new white paper, by President and CEO George Schindler, identifies the key organizational capabilities public and private sector executives need to help navigate significant economic, market and business changes caused by the COVID-19 pandemic.
CGI developed the STEM@CGI At Home program that offers fun STEM-based activity packs for children to do at home.These resources cover subjects ranging from coding, to environmental sustainability, to robotics that can be learnt through interesting hands-on tasks like building...
New virtual reality has increased vulnerability to threat actors. To respond to these heightened cybersecurity risks, CGI’s security experts are uniting by volunteering their expertise and time to better protect people, businesses and communities against cyber threats.
As the COVID-19 pandemic spread across the globe in the early months of 2020, government restrictions on work and travel began to dramatically impact the workforces of organizations, large and small. Organizations were not only required to transition their own...
Dear Valued Clients, A few weeks ago, we shared a message about our commitment to provide service continuity in these challenging times. Through collaborating with you and your teams, every day we experience your tremendous resolve to meet the needs...
In response to work and travel restrictions implemented in the midst of the pandemic, CGI designed a mobile app to help manage work statuses and travel permits.
In response to the COVID-19 pandemic, the U.S. government enacted the Coronavirus Aid, Relief, and Economic Security (CARES) Act to address the economic fallout of stay-at-home orders across the nation. As part of CARES, Congress set up a new Paycheck...
March 23, 2020 MONTREAL -- The Montreal Heart Institute announces that its Research Center is launching today a COVID-19 clinical study in Canada to determine whether short-term treatment would reduce the risk of pulmonary complications and related deaths. The clinical study...